ibuprofen has been researched along with Carcinoma, Renal Cell in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, X | 2 |
| Teng, Y | 2 |
| Zhu, C | 2 |
| Li, Z | 2 |
| Liu, T | 2 |
| Sun, Y | 2 |
| Han, S | 2 |
1 other study available for ibuprofen and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |